Subsequently, EBV latency II gene products such as LMP-1, -2, EBNA-, and EBER have been detected in breast cancer cells 102, 191, 192, and a meta-epidemiological study have also shown that EBV infection was highly associated with the risk of breast cancer development 193. This evidence concerns the gene PDLIM7 and breast cancer.